Affected by 63I-1-226 on 7/1/2027 26-18-102. DUR Board — Creation and membership — Expenses. (1) There is created a 12-member Drug Utilization Review Board responsible for implementation of a retrospective and prospective DUR program. (2) (a) Except as required by Subsection (2)(b), as terms of current board members expire, the executive director shall appoint each […]
Affected by 63I-1-226 on 7/1/2027 Effective 5/12/2020 26-18-103. DUR Board — Responsibilities. The board shall: (1) develop rules necessary to carry out its responsibilities as defined in this part; (2) oversee the implementation of a Medicaid retrospective and prospective DUR program in accordance with this part, including responsibility for approving provisions of contractual agreements between […]
Affected by 63I-1-226 on 7/1/2027 26-18-104. Confidentiality of records. (1) Information obtained under this part shall be treated as confidential or controlled information under Title 63G, Chapter 2, Government Records Access and Management Act. (2) The board shall establish procedures insuring that the information described in Subsection 26-18-103(16) is held confidential by the pharmacist, being […]
Affected by 63I-1-226 on 7/1/2027 26-18-105. Drug prior approval program. (1) A drug prior approval program approved or implemented by the board shall meet the following conditions: (a) except as provided in Subsection (2), a drug may not be placed on prior approval for other than medical reasons; (b) the board shall hold a public […]
Affected by 63I-1-226 on 7/1/2027 26-18-106. Advisory committees. The board may establish advisory committees to assist it in carrying out its duties under this part. Enacted by Chapter 273, 1992 General Session
Affected by 63I-1-226 on 7/1/2027 Effective 5/14/2019 26-18-107. Retrospective and prospective DUR. (1) The board, in cooperation with the division, shall include in its state plan the creation and implementation of a retrospective and prospective DUR program for Medicaid outpatient drugs to ensure that prescriptions are appropriate, medically necessary, and not likely to result in […]
Affected by 63I-1-226 on 7/1/2027 26-18-108. Penalties. Any person who violates the confidentiality provisions of this part is guilty of a class B misdemeanor. Enacted by Chapter 273, 1992 General Session
Affected by 63I-1-226 on 7/1/2027 26-18-109. Immunity. There is no liability on the part of, and no cause of action of any nature arises against any member of the board, its agents, or employees for any action or omission by them in effecting the provisions of this part. Enacted by Chapter 273, 1992 General Session
